膝關節軟骨修復市場規模、佔有率、成長分析（按治療類型、應用、最終用戶和地區）- 產業預測（2025 年至 2032 年）

2023 年全球膝關節軟骨修復市場規模為 12 億美元，預計 2024 年將成長至 12.7 億美元，2032 年將成長至 21.6 億美元，預測期內（2025-2032 年）的複合年成長率為 6.84%。

全球對膝關節軟骨修復解決方案的需求受到膝關節損傷、骨關節炎和運動相關損傷日益增多的顯著影響。積極的生活方式、人口老化和肥胖程度上升等因素導致膝關節退化，需要醫療介入。日益成長的臨床需求凸顯了退化性關節問題與整形外科重組治療之間的直接聯繫，促使醫療保健提供者和患者對膝關節軟骨修復技術的興趣日益濃厚。此外，生物材料、再生醫學和微創手術技術的進步正在重塑治療格局。人工軟骨產品核准的提高以及政府對整形外科研究的津貼進一步推動了市場擴張，預示著肌肉骨骼疾病治療領域將轉向成熟的治療方法，從而推動整體市場成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 顧客購買行為分析

膝關節軟骨修復市場規模（依治療類型及複合年成長率）（2025-2032）

• 市場概覽
• 手術修復
• 膝關節軟骨再生
• 基於細胞的軟骨表面置換

膝關節軟骨修復市場規模：按應用和複合年成長率（2025-2032）

• 市場概覽
• 股骨
• 脛骨
• 髕股軟骨修復

膝關節軟骨修復市場規模（依最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院
• 整形外科診所
• 門診手術中心

膝關節軟骨修復市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 按部門分類的公司佔有率分析
  • 收益同比對比（2022-2024 年）

主要企業簡介

• Smith & Nephew（United Kingdom）
• Zimmer Biomet Holdings Inc.（USA）
• Stryker Corporation（USA）
• Vericel Corporation（USA）
• DePuy Synthes（USA）
• CartiHeal Ltd.（Israel）
• Orthocell Limited（Australia）
• Mimix Biotherapeutics（Switzerland）
• TETEC AG（Germany）
• B. Braun Melsungen AG（Germany）
• Anika Therapeutics Inc.（USA）
• Tissue Regenix Group plc（United Kingdom）
• Biopolymer Solutions LLC（USA）
• Smith & Nephew Korea Ltd.（South Korea）
• ReLive Biotechnologies（India）

結論和建議

Global Knee Cartilage Repair Market size was valued at USD 1.2 Billion in 2023 poised to grow between USD 1.27 Billion in 2024 to USD 2.16 Billion by 2032, growing at a CAGR of 6.84% in the forecast period (2025-2032).

The global demand for knee cartilage repair solutions is significantly influenced by the increasing prevalence of knee injuries, osteoarthritis, and sports-related injuries. Factors such as active lifestyles, an aging population, and rising obesity levels contribute to knee joint degeneration, necessitating medical interventions. This growing clinical need highlights the direct connection between degenerative joint issues and orthopedic reconstruction treatments, leading to heightened interest from healthcare providers and patients in knee cartilage repair methods. Additionally, advancements in biomaterials, regenerative medicine, and minimally invasive surgical techniques are reshaping the treatment landscape. Increased approval rates of engineered cartilage products and government funding for orthopedic research further support market expansion, indicating a shift toward established care practices in managing musculoskeletal conditions, thus driving overall market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Knee Cartilage Repair market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Knee Cartilage Repair Market Segments Analysis

The global knee cartilage repair market is segmented based on treatment type, application, end user, and region. In terms of treatment type, the market is divided into surgical repair, knee cartilage regeneration, and cell-based cartilage resurfacing. Based on application, the market is categorized into femoral, tibial, and patellofemoral cartilage repair. By end user, the market is segmented into hospitals, orthopedic clinics, and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Central & South America, and the Middle East & Africa.

Driver of the Global Knee Cartilage Repair Market

The global knee cartilage repair market is propelled by several significant factors, including the growing occurrence of sports-related injuries, an aging population, and a higher prevalence of osteoarthritis. Both athletes and older individuals are increasingly seeking minimally invasive and regenerative treatments for knee cartilage repair to restore mobility and shorten recovery periods. Additionally, there is a strong emphasis on healing and effective procedures for cartilage restoration, which is encouraging widespread adoption in emerging markets as well as established economies. This trend underscores the demand for innovative solutions in knee cartilage repair across various healthcare landscapes.

Restraints in the Global Knee Cartilage Repair Market

The global knee cartilage repair market faces significant challenges primarily due to the high costs associated with advanced techniques such as cell-based therapies and robotic-assisted surgeries. These financial barriers hinder widespread adoption, particularly in lower-middle-income countries where access to such innovative treatments is limited. Additionally, issues related to restricted reimbursement options and high out-of-pocket expenses further obstruct patients' ability to seek necessary care, resulting in a slower overall market expansion. These factors collectively contribute to the market's stagnation, preventing both healthcare providers and patients from fully embracing and utilizing the latest advancements in knee cartilage repair technologies.

Market Trends of the Global Knee Cartilage Repair Market

The global knee cartilage repair market is witnessing a significant shift towards innovative regenerative and cell-based therapies that prioritize the restoration of natural cartilage function. Techniques such as autologous chondrocyte implantation (ACI), stem cell therapies, and scaffold-based approaches are gaining traction, offering promising solutions to alleviate pain and enhance recovery. This trend reflects a growing demand for minimally invasive procedures that not only improve joint functionality but also postpone the necessity for total knee replacement surgeries. As advancements in technology and research continue to emerge, the market is poised for transformative growth, driven by the increasing awareness and acceptance of these advanced treatment modalities.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Knee Cartilage Repair Market Size by Treatment Type & CAGR (2025-2032)

• Market Overview
• Surgical Repair
• Knee Cartilage Regeneration
• Cell-Based Cartilage Resurfacing

Global Knee Cartilage Repair Market Size by Application & CAGR (2025-2032)

• Market Overview
• Femoral
• Tibial
• Patellofemoral Cartilage Repair

Global Knee Cartilage Repair Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Centers

Global Knee Cartilage Repair Market Size & CAGR (2025-2032)

• North America (Treatment Type, Application, End User)
  • US
  • Canada
• Europe (Treatment Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Smith & Nephew (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vericel Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DePuy Synthes (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CartiHeal Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthocell Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mimix Biotherapeutics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TETEC AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anika Therapeutics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tissue Regenix Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopolymer Solutions LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew Korea Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReLive Biotechnologies (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations